Similarly, in a study involving recombinant VACV expressing interleukin-2 (IL-2), direct intratumoral injection resulted in neutrophil aggregation and tumor necrosis in some patients with malignant mesothelioma (17). This evidence concerns the gene IL2 and malignant mesothelioma.